Insider Trades41 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | Buy | ANNX | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | 30,646 | $1.85 | $950.3M | -19.22% | +185.71% | $56.7K | +19.88% | — | Stalk |
| Mar 2, 2026 | Sell | ANNX | Michael Overdorf | EVP & CHIEF BUSINESS OFFICER | 4,339 | $5.42 | $950.3M | -19.22% | +185.71% | $23.5K | -2.32% | — | Stalk |
| Mar 2, 2026 | Sell | ANNX | Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | 5,565 | $5.42 | $950.3M | -19.22% | +185.71% | $30.2K | -3.16% | — | Stalk |
| Mar 2, 2026 | Sell | ANNX | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | 5,566 | $5.42 | $950.3M | -19.22% | +185.71% | $30.2K | -3.48% | — | Stalk |
| Mar 2, 2026 | Sell | ANNX | Jamie Dananberg | CHIEF MEDICAL OFFICER | 5,820 | $5.43 | $950.3M | -19.22% | +185.71% | $31.6K | -4.50% | — | Stalk |
| Mar 2, 2026 | Sell | ANNX | Dean Richard Artis | EVP & CHIEF SCIENTIFIC OFFICER | 5,894 | $5.43 | $950.3M | -19.22% | +185.71% | $32.0K | -3.17% | — | Stalk |
| Feb 18, 2026 | Sell | ANNX | Dean Richard Artis | EVP & CHIEF SCIENTIFIC OFFICER | 5,290 | $5.10 | $950.3M | -19.22% | +185.71% | $27.0K | -4.11% | — | Stalk |
| Feb 18, 2026 | Sell | ANNX | Jamie Dananberg | CHIEF MEDICAL OFFICER | 5,290 | $5.10 | $950.3M | -19.22% | +185.71% | $27.0K | -6.74% | — | Stalk |
| Feb 18, 2026 | Sell | ANNX | Michael Overdorf | EVP & CHIEF BUSINESS OFFICER | 6,225 | $5.10 | $950.3M | -19.22% | +185.71% | $31.7K | -4.76% | — | Stalk |
| Feb 18, 2026 | Sell | ANNX | Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | 7,851 | $5.11 | $950.3M | -19.22% | +185.71% | $40.1K | -6.46% | — | Stalk |
| Feb 18, 2026 | Sell | ANNX | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | 7,857 | $5.11 | $950.3M | -19.22% | +185.71% | $40.1K | -7.48% | — | Stalk |
| Jul 14, 2025 | Sell | ANNX | Michael Overdorf | EVP & CHIEF BUSINESS OFFICER | 853 | $2.61 | $950.3M | -19.22% | +185.71% | $2.2K | -0.65% | — | Stalk |
| Jul 14, 2025 | Sell | ANNX | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | 1,116 | $2.58 | $950.3M | -19.22% | +185.71% | $2.9K | -1.05% | — | Stalk |
| Jul 14, 2025 | Sell | ANNX | Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | 1,117 | $2.58 | $950.3M | -19.22% | +185.71% | $2.9K | -0.91% | — | Stalk |
| Feb 18, 2025 | Sell | ANNX | Jamie Dananberg | CHIEF MEDICAL OFFICER | 5,521 | $2.96 | $950.3M | -19.22% | +185.71% | $16.3K | -14.16% | — | Stalk |
| Feb 18, 2025 | Sell | ANNX | Dean Richard Artis | EVP & CHIEF SCIENTIFIC OFFICER | 5,515 | $2.97 | $950.3M | -19.22% | +185.71% | $16.4K | -6.17% | — | Stalk |
| Feb 18, 2025 | Sell | ANNX | Michael Overdorf | EVP & CHIEF BUSINESS OFFICER | 6,618 | $2.95 | $950.3M | -19.22% | +185.71% | $19.5K | -7.10% | — | Stalk |
| Feb 18, 2025 | Sell | ANNX | Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | 6,912 | $2.92 | $950.3M | -19.22% | +185.71% | $20.2K | -8.16% | — | Stalk |
| Feb 18, 2025 | Sell | ANNX | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | 8,345 | $2.91 | $950.3M | -19.22% | +185.71% | $24.3K | -11.99% | — | Stalk |
| Feb 13, 2025 | Sell | ANNX | Michael Overdorf | EVP & CHIEF BUSINESS OFFICER | 1,425 | $2.99 | $950.3M | -19.22% | +185.71% | $4.3K | -1.51% | — | Stalk |
| Feb 13, 2025 | Sell | ANNX | Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | 1,786 | $2.98 | $950.3M | -19.22% | +185.71% | $5.3K | -2.07% | — | Stalk |
| Feb 13, 2025 | Sell | ANNX | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | 1,783 | $2.99 | $950.3M | -19.22% | +185.71% | $5.3K | -2.50% | — | Stalk |
| Feb 13, 2025 | Sell | ANNX | Douglas Love | PRESIDENT AND CEO | 5,021 | $2.95 | $950.3M | -19.22% | +185.71% | $14.8K | -1.41% | — | Stalk |
| Jan 6, 2025 | Buy | ANNX | Douglas Love | PRESIDENT AND CEO | 37,994 | $1.41 | $950.3M | -19.22% | +185.71% | $53.6K | +11.93% | — | Stalk |
| Oct 30, 2024 | Buy | ANNX | Douglas Love | PRESIDENT AND CEO | 114,449 | $1.85 | $950.3M | -19.22% | +185.71% | $211.7K | +24.32% | — | Stalk |
| Oct 15, 2024 | Sell | ANNX | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | 10,816 | $4.63 | $950.3M | -19.22% | +185.71% | $50.1K | +0.00% | 10b5-1 | Stalk |
| Sep 19, 2024 | Sell | ANNX | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | 4,500 | $7.10 | $950.3M | -19.22% | +185.71% | $31.9K | -100.00% | 10b5-1 | Stalk |
| Sep 12, 2024 | Sell | ANNX | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | 5,500 | $6.16 | $950.3M | -19.22% | +185.71% | $33.9K | -55.00% | 10b5-1 | Stalk |
| Sep 5, 2024 | Sell | ANNX | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | 5,500 | $5.64 | $950.3M | -19.22% | +185.71% | $31.0K | -35.48% | 10b5-1 | Stalk |
| Aug 29, 2024 | Sell | ANNX | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | 5,500 | $5.95 | $950.3M | -19.22% | +185.71% | $32.7K | -26.19% | 10b5-1 | Stalk |
| Jul 15, 2024 | Sell | ANNX | Michael Overdorf | EVP & CHIEF BUSINESS OFFICER | 784 | $6.02 | $950.3M | -19.22% | +185.71% | $4.7K | -0.82% | — | Stalk |
| Jul 15, 2024 | Sell | ANNX | Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | 1,104 | $6.03 | $950.3M | -19.22% | +185.71% | $6.7K | -1.26% | — | Stalk |
| Jul 15, 2024 | Sell | ANNX | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | 1,106 | $6.02 | $950.3M | -19.22% | +185.71% | $6.7K | -1.53% | — | Stalk |
| Feb 20, 2024 | Sell | ANNX | Michael Overdorf | EVP & CHIEF BUSINESS OFFICER | 1,951 | $5.48 | $950.3M | -19.22% | +185.71% | $10.7K | -0.79% | — | Stalk |
| Feb 20, 2024 | Sell | ANNX | Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | 2,593 | $5.53 | $950.3M | -19.22% | +185.71% | $14.3K | -1.06% | — | Stalk |
| Feb 20, 2024 | Sell | ANNX | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | 2,604 | $5.51 | $950.3M | -19.22% | +185.71% | $14.3K | -1.11% | — | Stalk |
| Feb 12, 2024 | Sell | ANNX | Michael Overdorf | EVP & CHIEF BUSINESS OFFICER | 1,349 | $5.53 | $950.3M | -19.22% | +185.71% | $7.5K | -2.70% | — | Stalk |
| Feb 12, 2024 | Sell | ANNX | Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | 1,809 | $5.54 | $950.3M | -19.22% | +185.71% | $10.0K | -3.81% | — | Stalk |
| Feb 12, 2024 | Sell | ANNX | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | 1,810 | $5.54 | $950.3M | -19.22% | +185.71% | $10.0K | -4.78% | — | Stalk |
| Feb 12, 2024 | Sell | ANNX | Douglas Love | PRESIDENT AND CEO | 5,782 | $5.54 | $950.3M | -19.22% | +185.71% | $32.0K | -2.86% | — | Stalk |
| Dec 27, 2023 | Sell | ANNX | Ted Yednock | EVP & Chief Innovation Officer | 42,000 | $3.07 | $950.3M | -19.22% | +185.71% | $129.1K | +0.00% | 10b5-1 | Stalk |